Insider Shareholders with Direct Ownership of Selecta Biosciences Inc (SELB)
This section provides a comprehensive overview of the insiders with direct ownership of Selecta Biosciences Inc (SELB). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
SELECTA BIOSCIENCES INC Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Timothy A Springer
Director |
10,145,410 | 1,760,757 | 8,455,706 $7.1 Million | 13 |
Nov 18, 2024
Added 0.24%
|
Carsten Brunn
President and CEO |
5,473,838 | 651,517 | 4,916,056 $4.13 Million | 32 |
Jan 02, 2024
Added 48.63%
|
Blaine Davis
Chief Financial Officer |
2,424,000 | 0 | 2,424,000 $2.04 Million | 1 |
Jan 02, 2024
Added 50.0%
|
Peter G Traber
Chief Medical Officer |
462,300 | 23,294 | 451,826 $379,533 | 18 |
Sep 25, 2023
Reduced 0.16%
|
Murat Kalayoglu
Director |
927,592 | 0 | 435,739 $366,020 | 3 |
Jan 02, 2024
Added 29.0%
|
Carrie Smith Cox
Director |
325,200 | 0 | 390,881 $328,340 | 3 |
Jan 02, 2024
Added 31.29%
|
Lloyd P. Johnston
Chief Operations Officer |
282,371 | 36,590 | 265,515 $223,032 | 12 |
Jan 05, 2023
Reduced 0.01%
|
Patrick J Zenner
Director |
178,000 | 0 | 233,248 $195,928 | 1 |
Jan 02, 2024
Added 43.28%
|
Takashi Kei Kishimoto
Chief Scientific Officer |
281,129 | 160,462 | 225,316 $189,265 | 14 |
May 31, 2023
Reduced 10.52%
|
Nishan M De Silva
Director |
185,000 | 0 | 185,000 $155,400 | 2 |
Jan 02, 2024
Added 49.04%
|
Aymeric Sallin
Director |
178,000 | 0 | 178,000 $149,520 | 1 |
Jan 02, 2024
Added 50.0%
|
Michael Singer
Director |
398,274 | 28,821 | 90,933 $76,383 | 4 |
Nov 19, 2024
Reduced 24.07%
|
Kevin Tan
Chief Financial Officer |
77,000 | 0 | 77,000 $64,680 | 2 |
Jan 03, 2022
Added 48.32%
|
Metin Kurtoglu
Chief Technology Officer |
1,665,721 | 134,721 | 51,033 $42,867 | 17 |
Dec 10, 2024
Reduced 5.38%
|
Christopher M Jewell
Chief Scientific Officer |
844,315 | 52,115 | 39,940 $33,549 | 6 |
Nov 20, 2024
Added 25.95%
|
Bradford D. Dahms
Chief Financial Officer |
38,000 | 0 | 38,000 $31,920 | 1 |
Jan 04, 2021
Added 50.0%
|
Timothy C Barabe
Director |
314,500 | 0 | 21,766 $18,283 | 7 |
Aug 12, 2024
Added 25.63%
|
Milos Miljkovic
Chief Medical Officer |
603,200 | 55,000 | 18,273 $15,349 | 5 |
Nov 15, 2024
Reduced 52.26%
|
Kemal Malik
Director |
5,933 | 0 | 5,933 $4,983 | 1 |
Jul 01, 2024
Added 50.0%
|